← All indications
Embolism
Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream.
Subtype terms (4)
More specific conditions that are subtypes of Embolism in the MeSH hierarchy.
- Embolism, Air
- Embolism, Amniotic Fluid
- Embolism, Fat
- Pulmonary Embolism
73 drugs (55 approved, 18 experimental)
Drugs by status
Approved for this indication (3)
Phase 4 trials (8)
Phase 3 trials (4)
Phase 1 trials (1)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (105)
- Eisai
- Bristol-Myers Squibb
- Aspen Pharmaceuticals
- Bracco
- Genentech
- Pfizer
- Bayer
- Biotronik, Inc.
- GlaxoSmithKline
- St. Jude Medical
- Danish Heart Foundation
- Foundation for Cardiovascular Research, Zurich
- National Heart, Lung, and Blood Institute (NHLBI)
- Huazhong University of Science and Technology
- Azienda Ospedaliera Universitaria Policlinico
- British Thoracic Society
- Cedars-Sinai Medical Center
- Cancer Research Network
- Harvard University
- Duke University
- Guangzhou Medical University
- Karadeniz Technical University
- Johns Hopkins University
- McMaster University
- Monash University
- Northwell Health
- Qingdao University
- RWTH Aachen University
- Shanxi Medical University
- Silesian University of Medicine
- +75 more
Organization Involved with Phase 3 Indications (58)
- Ekos Corp
- AstraZeneca
- Sanofi
- Novartis
- Cyclomedica Australia PTY Limited
- Supergene, LLC
- Azienda U.S.L. 1 di Massa e Carrara
- National Cancer Institute (NCI)
- Academic and Community Cancer Research United
- Brown University
- Advent Health
- Medical Center of Central Georgia
- Pirogov Russian National Research Medical University
- Red Cross Hospital Beverwijk
- Sanford Health
- Stanford University
- The TIMI Study Group
- Universidad Complutense de Madrid
- University of Florida
- University of Groningen
- University of Lausanne
- University of Padua
- University of Rochester
- University of Zurich
- Columbia University
- University of Connecticut
- University of Copenhagen
- University of Basel
- Tsinghua University
- University of Western Brittany
- +28 more
Organization Involved with Phase 2 Indications (31)
- Eli Lilly
- Archemix Corp.
- Kobe University
- Mallinckrodt
- Tasly Pharmaceuticals, Inc.
- vTv Therapeutics
- Fundación Pública Andaluza
- National Institutes of Health (NIH)
- National Cerebral and Cardiovascular Center
- Aarhus University
- University of Pittsburgh
- University of London
- Indiana University
- Mansoura University
- University of Milan
- University of Seville
- Cardiff University
- Peking University
- University of Vienna
- University of Toulouse
- Medpace, Inc.
- Medical University of Vienna
- Osaka Koseinenkin Hospital
- University of Gothenburg
- University of Mississippi
- University of Western Ontario
- National Institute for Health Research, United Kingdom
- Trillium Health Partners
- The University of Texas, Dallas
- Angde Biotech Pharmaceutical Co., Ltd.
- +1 more
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (23)
- Medical Compression Systems
- Marshfield Clinic Research Foundation
- ZonMw: The Netherlands Organisation for Health Research and Development
- Maastricht University
- Allegiance Health
- Hawler Medical University
- Newton-Wellesley Hospital
- Radboud University
- The New England Baptist Hospital
- Assiut University
- Fudan University
- Alliance Foundation Trials
- Hebrew University
- Hawler Ministry of Health
- University of Sao Paulo
- LDS Hospital, Salt Lake City, Utah
- Department of Health and Human Services
- Netherlands Heart Foundation
- Israel Science Foundation
- Deseret Foundation
- United States - Israel Binational Science Foundation
- Government of Israel
- Hospital Regional de Alta especialidad de Ixtapaluca